Mauro Barbareschi

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Eyebrow and Eyelash Outcomes During Baricitinib Treatment in Severe Alopecia Areata: A Real-World Study.

Eyebrow and Eyelash Outcomes During Baricitinib Treatment in Severe Alopecia Areata: A Real-World Study.

Journal: International journal of dermatology

Published: July 13, 2026

Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.

Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 11, 2026

Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study.

Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study.

Journal: Journal of the American Academy of Dermatology

Published: March 15, 2026

New-onset alopecia areata during calcitonin gene-related peptide inhibitor therapy: first reported case.

New-onset alopecia areata during calcitonin gene-related peptide inhibitor therapy: first reported case.

Journal: Dermatology reports

Published: January 31, 2026

Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.

Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.

Journal: American journal of clinical dermatology

Published: November 05, 2025

Trichoscopy of Terra Firma-Forme Dermatosis of the Scalp: A Case Report.

Trichoscopy of Terra Firma-Forme Dermatosis of the Scalp: A Case Report.

Journal: Skin appendage disorders

Published: March 02, 2025

Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results.

Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: February 28, 2025

Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study.

Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study.

Journal: The Journal of dermatological treatment

Published: January 06, 2025

Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study.

Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study.

Journal: Clinical and experimental dermatology

Published: December 03, 2024

A Real-World Approach to Trifarotene Treatment in Patients with Acne and Acne Sequelae Based on the Experience of the Italian Acne Board.

A Real-World Approach to Trifarotene Treatment in Patients with Acne and Acne Sequelae Based on the Experience of the Italian Acne Board.

Journal: Dermatology and therapy

Published: October 17, 2024

Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients.

Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients.

Journal: Italian journal of dermatology and venereology

Published: May 29, 2024

Effectiveness of dupilumab in the treatment of alopecia areata in patients with concurrent atopic dermatitis: a real-life retrospective study.

Effectiveness of dupilumab in the treatment of alopecia areata in patients with concurrent atopic dermatitis: a real-life retrospective study.

Journal: International journal of dermatology

Published: February 27, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026